| MEPS HC 239A CODEBOOK |
| 2022 PRESCRIBED MEDICINES |
| DATE: July 1, 2024 |
| Variable Name: |
TC1S1 |
| Description: |
MULTUM THERAPEUTIC SUB-CLASS #1 FOR TC1 |
| Format: |
3.0 |
| Type: |
NUM |
| Start: |
442 |
| End: |
444 |
|
|
|
| -15 CANNOT BE COMPUTED |
5,746 |
74,628,470 |
| -1 INAPPLICABLE |
6,557 |
75,737,184 |
| 2 AMEBICIDES |
204 |
2,692,449 |
| 4 ANTIFUNGALS |
464 |
5,921,684 |
| 5 ANTIMALARIAL AGENTS |
1,247 |
15,529,783 |
| 7 ANTIVIRAL AGENTS |
1,671 |
21,687,548 |
| 9 CEPHALOSPORINS |
811 |
10,814,064 |
| 11 MACROLIDE DERIVATIVES |
677 |
8,982,879 |
| 12 MISCELLANEOUS ANTIBIOTICS |
3 |
68,342 |
| 13 PENICILLINS |
1,883 |
28,862,292 |
| 14 QUINOLONES |
357 |
3,864,529 |
| 15 SULFONAMIDES |
318 |
3,932,844 |
| 16 TETRACYCLINES |
83 |
1,084,725 |
| 17 URINARY ANTI-INFECTIVES |
306 |
3,870,389 |
| 19 ANTIHYPERLIPIDEMIC AGENTS |
18,551 |
219,754,261 |
| 23 ANTIMETABOLITES |
292 |
4,565,259 |
| 24 ANTINEOPLASTIC HORMONES |
726 |
7,687,822 |
| 25 MISCELLANEOUS ANTINEOPLASTICS |
160 |
1,908,464 |
| 34 IN VIVO DIAGNOSTIC BIOLOGICALS |
6 |
43,010 |
| 42 ANGIOTENSIN CONVERTING ENZYME INHIBITORS |
7,681 |
94,608,248 |
| 43 ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING |
327 |
3,941,372 |
| 44 ANTIADRENERGIC AGENTS, CENTRALLY ACTING |
915 |
10,454,528 |
| 45 ANTIANGINAL AGENTS |
769 |
9,130,798 |
| 46 ANTIARRHYTHMIC AGENTS |
2,098 |
22,845,116 |
| 47 BETA-ADRENERGIC BLOCKING AGENTS |
8,549 |
99,408,919 |
| 48 CALCIUM CHANNEL BLOCKING AGENTS |
6,695 |
75,484,369 |
| 49 DIURETICS |
7,416 |
85,182,247 |
| 51 MISCELLANEOUS CARDIOVASCULAR AGENTS |
39 |
443,807 |
| 53 VASODILATORS |
527 |
5,298,188 |
| 54 VASOPRESSORS |
166 |
2,844,055 |
| 55 ANTIHYPERTENSIVE COMBINATIONS |
3,366 |
39,652,536 |
| 56 ANGIOTENSIN II INHIBITORS |
5,639 |
69,619,231 |
| 58 ANALGESICS |
14,686 |
170,817,188 |
| 64 ANTICONVULSANTS |
9,816 |
112,802,401 |
| 65 ANTIEMETIC/ANTIVERTIGO AGENTS |
1,685 |
21,707,643 |
| 66 ANTIPARKINSON AGENTS |
835 |
9,310,372 |
| 67 ANXIOLYTICS, SEDATIVES, AND HYPNOTICS |
4,744 |
59,339,638 |
| 71 CNS STIMULANTS |
4,290 |
73,403,990 |
| 73 MUSCLE RELAXANTS |
2,951 |
33,543,354 |
| 80 MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENT |
253 |
3,747,711 |
| 82 ANTICOAGULANTS |
3,300 |
36,499,067 |
| 83 ANTIPLATELET AGENTS |
1,421 |
15,747,677 |
| 88 ANTACIDS |
126 |
1,347,937 |
| 90 ANTIDIARRHEALS |
135 |
1,209,739 |
| 91 DIGESTIVE ENZYMES |
104 |
1,246,442 |
| 94 H2 ANTAGONISTS |
1,185 |
13,323,039 |
| 95 LAXATIVES |
892 |
9,705,216 |
| 96 MISCELLANEOUS GI AGENTS |
203 |
2,319,676 |
| 98 ADRENAL CORTICAL STEROIDS |
2,307 |
30,704,613 |
| 99 ANTIDIABETIC AGENTS |
19,918 |
238,582,221 |
| 101 SEX HORMONES |
3,717 |
62,945,441 |
| 103 THYROID HORMONES |
6,775 |
88,735,227 |
| 104 IMMUNOSUPPRESSIVE AGENTS |
172 |
2,334,733 |
| 106 ANTIDOTES |
11 |
99,891 |
| 116 IRON PRODUCTS |
877 |
10,491,560 |
| 117 MINERALS AND ELECTROLYTES |
1,968 |
20,553,955 |
| 119 VITAMINS |
3,907 |
46,523,380 |
| 120 VITAMIN AND MINERAL COMBINATIONS |
441 |
5,239,359 |
| 123 ANTIHISTAMINES |
2,439 |
29,166,244 |
| 124 ANTITUSSIVES |
373 |
4,893,644 |
| 125 BRONCHODILATORS |
9,007 |
100,950,997 |
| 127 DECONGESTANTS |
31 |
329,385 |
| 128 EXPECTORANTS |
65 |
450,288 |
| 130 RESPIRATORY INHALANT PRODUCTS |
599 |
7,799,273 |
| 132 UPPER RESPIRATORY COMBINATIONS |
353 |
5,181,019 |
| 135 ANTISEPTIC AND GERMICIDES |
91 |
1,549,907 |
| 136 DERMATOLOGICAL AGENTS |
3,723 |
48,804,942 |
| 146 MOUTH AND THROAT PRODUCTS |
133 |
1,841,612 |
| 147 OPHTHALMIC PREPARATIONS |
3,994 |
46,107,024 |
| 148 OTIC PREPARATIONS |
151 |
1,942,083 |
| 192 ANTIRHEUMATICS |
136 |
1,449,438 |
| 194 ANTIGOUT AGENTS |
1,442 |
17,452,498 |
| 219 NUTRACEUTICAL PRODUCTS |
259 |
2,702,346 |
| 220 HERBAL PRODUCTS |
250 |
2,892,587 |
| 240 LINCOMYCIN DERIVATIVES |
169 |
1,907,413 |
| 243 LEUKOTRIENE MODIFIERS |
2,288 |
29,187,952 |
| 247 NASAL PREPARATIONS |
2,072 |
25,120,434 |
| 249 ANTIDEPRESSANTS |
15,076 |
198,507,140 |
| 251 ANTIPSYCHOTICS |
2,307 |
25,616,465 |
| 264 URINARY ANTISPASMODICS |
1,015 |
11,443,433 |
| 272 PROTON PUMP INHIBITORS |
7,519 |
93,022,246 |
| 277 5-AMINOSALICYLATES |
102 |
1,327,419 |
| 288 5-ALPHA-REDUCTASE INHIBITORS |
872 |
9,896,436 |
| 293 GLUCOSE ELEVATING AGENTS |
2 |
17,169 |
| 303 AGENTS FOR PULMONARY HYPERTENSION |
531 |
6,484,272 |
| 312 CHOLINERGIC AGONISTS |
45 |
659,991 |
| 313 CHOLINESTERASE INHIBITORS |
394 |
4,253,434 |
| 320 SMOKING CESSATION AGENTS |
2,010 |
26,505,041 |
| 355 FUNCTIONAL BOWEL DISORDER AGENTS |
688 |
7,401,964 |
| 363 PROBIOTICS |
19 |
200,658 |
| 397 MULTIKINASE INHIBITORS |
31 |
401,430 |
| 401 CD20 MONOCLONAL ANTIBODIES |
15 |
164,182 |
| 403 MTOR INHIBITORS |
4 |
34,854 |
| 409 BONE RESORPTION INHIBITORS |
668 |
7,350,065 |
| 460 PHOSPHATE BINDERS |
14 |
103,669 |
| 482 ANGIOTENSIN RECEPTOR BLOCKERS AND NEPRILY |
307 |
3,183,215 |
| 488 ANTICOAGULANT REVERSAL AGENTS |
4 |
66,436 |
| 504 ANTIMANIC AGENTS |
143 |
1,861,585 |
| 516 NORADRENERGIC UPTAKE INHIBITORS FOR ADHD |
102 |
1,822,925 |
| 519 ALPHA-ADRENORECEPTOR ANTAGONISTS |
2,194 |
26,229,466 |
| TOTAL |
232,605 |
2,839,113,471 |
Return to list of variables
|
Back
Email Updates
